Terms: = Ovarian cancer AND IDH1, IDP, 3417, ENSG00000138413, IDH, PICD, O75874
32 results:
1. Mutation analysis of the TERT gene in ovarian cancer patients of the Turkish population by next generation sequencing method.
Capar Gorali B; Gulec Yılmaz S; Akdeniz FT; Attar R; İsbir T
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):51-55. PubMed ID: 38015541
[TBL] [Abstract] [Full Text] [Related]
2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
3. Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers.
Biswas S; Mandal G; Anadon CM; Chaurio RA; Lopez-Bailon LU; Nagy MZ; Mine JA; Hänggi K; Sprenger KB; Innamarato P; Harro CM; Powers JJ; Johnson J; Fang B; Eysha M; Nan X; Li R; Perez BA; Curiel TJ; Yu X; Rodriguez PC; Conejo-Garcia JR
Immunity; 2023 Nov; 56(11):2570-2583.e6. PubMed ID: 37909039
[TBL] [Abstract] [Full Text] [Related]
4. Proteomic landscape of primary and metastatic brain tumors for heterogeneity discovery.
Yang S; Zhou C; Zhang L; Xiong Y; Zheng Y; Bian L; Liu X
Proteomics Clin Appl; 2024 Mar; 18(2):e2300010. PubMed ID: 37726528
[TBL] [Abstract] [Full Text] [Related]
5. ovarian juvenile granulosa cell tumors with Ollier's disease in children with idh1 gene somatic mutation.
Zhang J; Hua R; Ma L; Liu C; Zhang Y; Lü X; Wang T; Wan N
Front Endocrinol (Lausanne); 2023; 14():1093273. PubMed ID: 37324278
[TBL] [Abstract] [Full Text] [Related]
6. Mismatch repair-deficient glioma with spatially distinct idh-mutant and idh-wild type components arising in the setting of Lynch syndrome.
Tan H; Nerison C; Stateler C; Bowden SG; Raslan AM; Ambady P; Barajas RF; Wood MD
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 37076313
[TBL] [Abstract] [Full Text] [Related]
7. Silybin suppresses ovarian cancer cell proliferation by inhibiting isocitrate dehydrogenase 1 activity.
Wei Z; Ye S; Feng H; Zeng C; Dong X; Zeng X; Zeng L; Lin X; Liu Q; Yao J
Cancer Sci; 2022 Sep; 113(9):3032-3043. PubMed ID: 35730256
[TBL] [Abstract] [Full Text] [Related]
8. Juvenile granulosa cell tumor associated with Ollier disease.
Littrell LA; Inwards CY; Hazard FK; Wenger DE
Skeletal Radiol; 2023 Mar; 52(3):605-612. PubMed ID: 35296906
[TBL] [Abstract] [Full Text] [Related]
9. BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme.
Xavier MA; Rezende F; Titze-de-Almeida R; Cornelissen B
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439854
[TBL] [Abstract] [Full Text] [Related]
10. Update on the imaging features of the enchondromatosis syndromes.
Sharif B; Lindsay D; Saifuddin A
Skeletal Radiol; 2022 Apr; 51(4):747-762. PubMed ID: 34302201
[TBL] [Abstract] [Full Text] [Related]
11. Bcl2l10 induces metabolic alterations in ovarian cancer cells by regulating the TCA cycle enzymes SDHD and idh1.
Lee SY; Kwon J; Lee KA
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649794
[TBL] [Abstract] [Full Text] [Related]
12. Differential expression of the BCAT isoforms between breast cancer subtypes.
Shafei MA; Flemban A; Daly C; Kendrick P; White P; Dean S; Qualtrough D; Conway ME
Breast Cancer; 2021 May; 28(3):592-607. PubMed ID: 33367952
[TBL] [Abstract] [Full Text] [Related]
13.
Górka M; Żerko S; Konrat R; Koźmiński W; Kurzbach D
Biomol NMR Assign; 2020 Oct; 14(2):289-293. PubMed ID: 32583165
[TBL] [Abstract] [Full Text] [Related]
14. PARP goes the weasel! Emerging role of PARP inhibitors in acute leukemias.
Fritz C; Portwood SM; Przespolewski A; Wang ES
Blood Rev; 2021 Jan; 45():100696. PubMed ID: 32482307
[TBL] [Abstract] [Full Text] [Related]
15. Genetic Causes of Rare Pediatric ovarian Tumors.
Plevová P; Geržová H
Klin Onkol; 2019; 32(Supplementum2):79-91. PubMed ID: 31409083
[TBL] [Abstract] [Full Text] [Related]
16. Targeting idh1 as a Prosenescent Therapy in High-grade Serous ovarian cancer.
Dahl ES; Buj R; Leon KE; Newell JM; Imamura Y; Bitler BG; Snyder NW; Aird KM
Mol Cancer Res; 2019 Aug; 17(8):1710-1720. PubMed ID: 31110157
[TBL] [Abstract] [Full Text] [Related]
17. Death Receptor 6 (DR6) Is Overexpressed in Astrocytomas.
Stegmann S; Werner JM; Kuhl S; Röhn G; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
Anticancer Res; 2019 May; 39(5):2299-2306. PubMed ID: 31092421
[TBL] [Abstract] [Full Text] [Related]
18. Prospective Clinical Sequencing of Adult Glioma.
Zheng S; Alfaro-Munoz K; Wei W; Wang X; Wang F; Eterovic AK; Shaw KRM; Meric-Bernstam F; Fuller GN; Chen K; Verhaak RG; Mills GB; Yung WKA; Weathers SP; de Groot JF
Mol Cancer Ther; 2019 May; 18(5):991-1000. PubMed ID: 30926639
[TBL] [Abstract] [Full Text] [Related]
19. Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: A retrospective study.
Nie D; Gong H; Mao X; Li Z
Gynecol Oncol; 2019 Feb; 152(2):259-264. PubMed ID: 30558974
[TBL] [Abstract] [Full Text] [Related]
20. Paediatric diffuse leptomeningeal tumor with glial and neuronal differentiation harbouring chromosome 1p/19q co-deletion and H3.3 K27M mutation: unusual molecular profile and its therapeutic implications.
Nambirajan A; Suri V; Kedia S; Goyal K; Malgulwar PB; Khanna G; Panda PK; Gulati S; Garg A; Sharma MC
Brain Tumor Pathol; 2018 Jul; 35(3):186-191. PubMed ID: 30030640
[TBL] [Abstract] [Full Text] [Related]
[Next]